2021
DOI: 10.1371/journal.pone.0257512
|View full text |Cite
|
Sign up to set email alerts
|

Modelling and optimal control of multi strain epidemics, with application to COVID-19

Abstract: Reinfection and multiple viral strains are among the latest challenges in the current COVID-19 pandemic. In contrast, epidemic models often consider a single strain and perennial immunity. To bridge this gap, we present a new epidemic model that simultaneously considers multiple viral strains and reinfection due to waning immunity. The model is general, applies to any viral disease and includes an optimal control formulation to seek a trade-off between the societal and economic costs of mitigation. We validate… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
51
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 58 publications
(57 citation statements)
references
References 44 publications
2
51
0
Order By: Relevance
“…Regarding the input controls used in the formulation of the corresponding OCPs, some previous works have considered only non-pharmaceutical interventions against COVID-19, such as isolation of the population [27]; quarantining, hospitalization interventions, and treatment of infected people [15,17]; isolation, quarantine, and public health education [16], sensitization, quarantine, diagnosis, and monitoring and psychological support [19]; public health education, treatment of infected individuals, and health care measures for asymptomatic infectious people [21]; and use of face-masks, hand sanitizer, and social distancing; treatment of patients and active screening with testing; and prevention against recurrence and reinfection of people who have recovered [26]. Fewer works have focused on pharmaceutical measures, such as allocation of the treatment [18] and vaccine administration [20,[23][24][25].…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…Regarding the input controls used in the formulation of the corresponding OCPs, some previous works have considered only non-pharmaceutical interventions against COVID-19, such as isolation of the population [27]; quarantining, hospitalization interventions, and treatment of infected people [15,17]; isolation, quarantine, and public health education [16], sensitization, quarantine, diagnosis, and monitoring and psychological support [19]; public health education, treatment of infected individuals, and health care measures for asymptomatic infectious people [21]; and use of face-masks, hand sanitizer, and social distancing; treatment of patients and active screening with testing; and prevention against recurrence and reinfection of people who have recovered [26]. Fewer works have focused on pharmaceutical measures, such as allocation of the treatment [18] and vaccine administration [20,[23][24][25].…”
Section: Discussionmentioning
confidence: 99%
“…Regarding the objective functional used in the formulation of the corresponding OCPs, some previous works have considered just a single optimality criterion, such as the minimization of the number of infected people [18], the number of deaths [27], or the years of life lost due to premature mortality and the years lost due to disability [23]. Some other works have considered and compared several optimality criteria, such as minimizing the number of new infections, the number of deaths, the life years lost, and the quality-adjusted life years lost due to death [20], or minimizing the number of symptomatic infections, the number of deaths, the number of cases requiring non-ICU hospitalization, and the number of cases requiring ICU hospitalization [24].…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations